J&J may not meet US COVID-19 vaccine supply target by spring: NYT
Johnson & Johnson is facing unexpected delays in the manufacturing of its coronavirus vaccine and may not be able to supply the doses it promised the federal government by spring, the New York Times reported on Wednesday.
US federal officials have been told that J&J has fallen as much as two months behind the original production schedule and will not catch up until the end of April, when it was supposed to have delivered more than 60 million doses, the NYT reported, citing people familiar with the situation.
The company and the US Department of Health and Human Services did not immediately respond to Reuters requests for comment.
Earlier this week, J&J’s chief executive officer said the company was on track to have close to a billion COVID-19 vaccine doses by 2021-end.
(Source: Reuters)
Russian court orders Google to pay staggering fine of $20 decillion
US police arrest pro-Palestine protesters for 'occupying' Minnesota University building
Over 200 pro-Palestinian protesters arrested outside New York Stock Exchange
Iran lauds Pakistani army’s strikes against terrorist hideouts along border
VIDEO | Netanyahu’s imaginary victories
UN expert slams ‘obscuring’ media coverage of Israeli violence in Amsterdam
Over 100 killed in fresh Israeli onslaughts on Gaza, Lebanon
Foreign presidential elections will not affect Iran: Parl. speaker
VIDEO | Beaten Democrats look warily at four more years of Trump
VIDEO | A look at Trump's past actions
US, UK warplanes pound Yemeni capital Sana’a, other regions
PressTV NEWSLETTER
now
This makes it easy to access the Press TV website
